 |
International Journal for Research Trends and Innovation
International Peer Reviewed & Refereed Journals, Open Access Journal
ISSN Approved Journal No: 2456-3315 | Impact factor: 8.14 | ESTD Year: 2016
Scholarly open access journals, Peer-reviewed, and Refereed Journals, Impact factor 8.14 (Calculate by google scholar and Semantic Scholar | AI-Powered Research Tool) , Multidisciplinary, Monthly, Indexing in all major database & Metadata, Citation Generator, Digital Object Identifier(DOI)
|
Issue: December 2025
Volume 10 | Issue 12
Review Result and Publication of Paper within : 2-3 days
Click Here For more DetailsFor Authors
Forms / Download
Published Issue Details
Editorial Board
Other IMP Links
Facts & Figure
Impact Factor : 8.14
Issue per Year : 12
Volume Published : 10
Issue Published : 115
Article Submitted : 19457
Article Published : 8041
Total Authors : 21252
Total Reviewer : 769
Total Countries : 144
Indexing Partner
Licence
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
|
Published Paper Details
|
|
| Paper Title: | Sotagliflozin - The first double SGLT inhibitor |
| Authors Name: | Vaishnavi M. Papal , Amol S. Naikwadi |
| Download E-Certificate: | Download |
| Author Reg. ID: |
IJRTI_188937
|
| Published Paper Id: | IJRTI2401037 |
| Published In: | Volume 9 Issue 1, January-2024 |
| DOI: | |
| Abstract: | Sotagliflozin is a double sodium-glucose co-carrier 2 and 1 (SGLT2/1) inhibitor for the treatment of both sort 1 (T1D) and type 2 diabetes (T2D). Sotagliflozin restrains renal sodium-glucose co-carrier 2 (deciding significant discharge of glucose in the pee, similarly as other, currently accessible SGLT-2 specific inhibitors) and digestive SGLT-1, deferring glucose ingestion and along these lines lessening post prandial glucose. All around planned clinical preliminaries, have shown that sotagliflozin (as monotherapy or add-on treatment to other enemy of hyperglycemic specialists) improves glycated heamoglobin in grown-ups with T2D, with beneficial effects on bodyweight and circulatory strain. Comparable outcomes have been acquired in grown-ups with T1D treated with either ceaseless subcutaneous insulin mixture or various everyday insulin infusions, even after insulin streamlining. An as yet progressing stage 3 review is right now assessing the effect of sotagliflozin on cardiovascular results (ClinicalTrials.gov NCT03315143). In this survey we represent the benefits and impediments of double SGLT 2/1 hindrance, to more readily portray and research its instruments of activity and possibilities. |
| Keywords: | SGLT2/1 inhibitors, Diabetes, Hypoglycemic therapy |
| Cite Article: | "Sotagliflozin - The first double SGLT inhibitor", International Journal of Science & Engineering Development Research (www.ijrti.org), ISSN:2455-2631, Vol.9, Issue 1, page no.215 - 219, January-2024, Available :http://www.ijrti.org/papers/IJRTI2401037.pdf |
| Downloads: | 000205136 |
| ISSN: |
2456-3315 | IMPACT FACTOR: 8.14 Calculated By Google Scholar| ESTD YEAR: 2016 An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 8.14 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator |
| Publication Details: |
Published Paper ID: IJRTI2401037
Registration ID:188937
Published In: Volume 9 Issue 1, January-2024
DOI (Digital Object Identifier):
Page No: 215 - 219 Country: Dhamangoan awari, Maharashtra, India Research Area: Pharmacy Publisher : IJ Publication Published Paper URL : https://www.ijrti.org/viewpaperforall?paper=IJRTI2401037 Published Paper PDF: https://www.ijrti.org/papers/IJRTI2401037 |
| Share Article: | |
|
Click Here to Download This Article |
|
| Article Preview | |
|
|
|
Major Indexing from www.ijrti.org
| Google Scholar | ResearcherID Thomson Reuters | Mendeley : reference manager | Academia.edu |
| arXiv.org : cornell university library | Research Gate | CiteSeerX | DOAJ : Directory of Open Access Journals |
| DRJI | Index Copernicus International | Scribd | DocStoc |
ISSN Details
 |
 |
|
ISSN: 2456-3315
Impact Factor: 8.14 and ISSN APPROVED,
Journal Starting Year (ESTD) : 2016
DOI (A digital object identifier)
| Providing A digital object identifier by DOI.ONE How to Get DOI? |
Conference
Open Access License Policy
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
Important Details
Join RMS/Earn 300
WhatsApp
Click Here
Click Here
Indexing Partner |
|||
| Copyright © 2025 - All Rights Reserved - IJRTI | |||